Tumours

Problems

Chemosensitizing Non-Hodgkin Lymphoma cells with protein synthesis inhibitors
Prof Anne Willis (School of Pharmacy, University of Nottingham)
In vivo delivery of gene therapy to tumours
Dr Kerry Fisher (Clinical Pharmacology, University of Oxford)
Dr Len Seymour (Clinical Pharmacology, University of Oxford)
Effects of a new anti-tumour drug, fibrinogen E-fragment, in vivo: differential effects on the outer versus the inner areas of tumours
Prof Claire Lewis (Medical School, University of Sheffield)